413 related articles for article (PubMed ID: 29396352)
1. Risk of high-risk human papillomavirus infection and cervical precancerous lesions with past or current trichomonas infection: a pooled analysis of 25,054 women in rural China.
Feng RM; Z Wang M; Smith JS; Dong L; Chen F; Pan QJ; Zhang X; Qiao YL; Zhao FH
J Clin Virol; 2018; 99-100():84-90. PubMed ID: 29396352
[TBL] [Abstract][Full Text] [Related]
2. Co-infection with trichomonas vaginalis increases the risk of cervical intraepithelial neoplasia grade 2-3 among HPV16 positive female: a large population-based study.
Yang M; Li L; Jiang C; Qin X; Zhou M; Mao X; Xing H
BMC Infect Dis; 2020 Sep; 20(1):642. PubMed ID: 32873233
[TBL] [Abstract][Full Text] [Related]
3. High-risk human papillomavirus genotype distribution and attribution to cervical cancer and precancerous lesions in a rural Chinese population.
Zhao XL; Hu SY; Zhang Q; Dong L; Feng RM; Han R; Zhao FH
J Gynecol Oncol; 2017 Jul; 28(4):e30. PubMed ID: 28541628
[TBL] [Abstract][Full Text] [Related]
4. An association between Trichomonas vaginalis and high-risk human papillomavirus in rural Tanzanian women undergoing cervical cancer screening.
Lazenby GB; Taylor PT; Badman BS; McHaki E; Korte JE; Soper DE; Young Pierce J
Clin Ther; 2014 Jan; 36(1):38-45. PubMed ID: 24417784
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology of Trichomonas vaginalis and human papillomavirus infection detected by real-time PCR in flanders.
Depuydt CE; Leuridan E; Van Damme P; Bogers J; Vereecken AJ; Donders GG
Gynecol Obstet Invest; 2010; 70(4):273-80. PubMed ID: 21051847
[TBL] [Abstract][Full Text] [Related]
6. Association between high risk human papillomavirus infection and co-infection with Candida spp. and Trichomonas vaginalis in women with cervical premalignant and malignant lesions.
Ghosh I; Muwonge R; Mittal S; Banerjee D; Kundu P; Mandal R; Biswas J; Basu P
J Clin Virol; 2017 Feb; 87():43-48. PubMed ID: 27992790
[TBL] [Abstract][Full Text] [Related]
7. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
[TBL] [Abstract][Full Text] [Related]
8. Prevalence characteristics of single and multiple HPV infections in women with cervical cancer and precancerous lesions in Beijing, China.
Li M; Du X; Lu M; Zhang W; Sun Z; Li L; Ye M; Fan W; Jiang S; Liu A; Wang M; Meng Y; Li Y
J Med Virol; 2019 Mar; 91(3):473-481. PubMed ID: 30281807
[TBL] [Abstract][Full Text] [Related]
9. Human Papillomavirus Genotyping to Predict the Risk of Cervical Precancerous Lesions or Cancer in Women with Minor Abnormal Cytology in China.
Lin CQ; Cui JF; Zhang X; Pan QJ; Chen W; Qiao YL
Acta Cytol; 2015; 59(5):405-11. PubMed ID: 26565687
[TBL] [Abstract][Full Text] [Related]
10. [Real-world research on cervical cancer screening program and effect evaluation for Chinese population].
Zhao YQ; Dai Y; Dang L; Kong LH; Zhang Y; Feng RM; Qiao YL; Lang JH
Zhonghua Zhong Liu Za Zhi; 2018 Oct; 40(10):764-771. PubMed ID: 30392341
[No Abstract] [Full Text] [Related]
11. [Prevalence of human papillomavirus infection and risk of cervical cancer or precancerous lesions in 15 years follow up: a prospective cohort study].
Zhang Q; Hu SY; Feng RM; Dong L; Chen F; Zhang X; Pan QJ; Ma JF; Shi SD; Zhao FH; Qiao YL
Zhonghua Zhong Liu Za Zhi; 2016 Oct; 38(10):792-797. PubMed ID: 27784468
[No Abstract] [Full Text] [Related]
12. Prospective comparison of hybrid capture 2 and SPF₁₀-LiPA for carcinogenic human papillomavirus detection and risk prediction of cervical cancer: a population-based cohort study in China.
Dong L; Feng RM; Zhang L; Xu XQ; Zhao XL; Wang MZ; Qiao YL; Zhao FH
J Gynecol Oncol; 2017 Sep; 28(5):e66. PubMed ID: 28657227
[TBL] [Abstract][Full Text] [Related]
13. [Association between high risk human papillomavirus DNA load and cervical lesions in different infection status].
Li TY; Wu ZN; Jiang MY; Cui JF; Liu B; Chen F; Chen W
Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):475-480. PubMed ID: 29936777
[No Abstract] [Full Text] [Related]
14. A Pooled Analysis to Compare the Clinical Characteristics of Human Papillomavirus-positive and -Negative Cervical Precancers.
Castle PE; Pierz AJ; Adcock R; Aslam S; Basu PS; Belinson JL; Cuzick J; El-Zein M; Ferreccio C; Firnhaber C; Franco EL; Gravitt PE; Isidean SD; Lin J; Mahmud SM; Monsonego J; Muwonge R; Ratnam S; Safaeian M; Schiffman M; Smith JS; Swarts A; Wright TC; Van De Wyngard V; Xi LF
Cancer Prev Res (Phila); 2020 Oct; 13(10):829-840. PubMed ID: 32655005
[TBL] [Abstract][Full Text] [Related]
15. [Analysis of high risk factors associated with cervical intraepithelial neoplasia in married women aged 25 - 54 years in Beijing between 2007 - 2008].
Li CD; Zhang WY; Wu MH; Zhang SW; Zhou BL; Zhu L; Pan J; Wang JD
Zhonghua Fu Chan Ke Za Zhi; 2010 Oct; 45(10):757-61. PubMed ID: 21176557
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus infection and associated factors for cervical intraepithelial neoplasia in women living with HIV in China: a cross-sectional study.
Wang Q; Ma X; Zhang X; Ong JJ; Jing J; Zhang L; Wang LH
Sex Transm Infect; 2019 Mar; 95(2):140-144. PubMed ID: 30337414
[TBL] [Abstract][Full Text] [Related]
17. Prediction of recurrence after treatment for high-grade cervical intraepithelial neoplasia: the role of human papillomavirus testing and age at conisation.
Verguts J; Bronselaer B; Donders G; Arbyn M; Van Eldere J; Drijkoningen M; Poppe W
BJOG; 2006 Nov; 113(11):1303-7. PubMed ID: 16978225
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in the Republic of Korea, 2014-2016.
Ouh YT; Min KJ; Cho HW; Ki M; Oh JK; Shin SY; Hong JH; Lee JK
J Gynecol Oncol; 2018 Jan; 29(1):e14. PubMed ID: 29185272
[TBL] [Abstract][Full Text] [Related]
19. Liquid-based cytology and human papillomavirus testing: a pooled analysis using the data from 13 population-based cervical cancer screening studies from China.
Pan QJ; Hu SY; Guo HQ; Zhang WH; Zhang X; Chen W; Cao J; Jiang Y; Zhao FH; Qiao YL
Gynecol Oncol; 2014 May; 133(2):172-9. PubMed ID: 24631450
[TBL] [Abstract][Full Text] [Related]
20. High-risk HPV detection and associated cervical lesions in a population of French menopausal women.
Tifaoui N; Maudelonde T; Combecal J; Vallo R; Doutre S; Didelot MN; Nagot N; Segondy M; Boulle N
J Clin Virol; 2018 Nov; 108():12-18. PubMed ID: 30196012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
